InDevR’s technology is poised to change the face of how we screen donors, incoming raw materials, and QC/QA release manufactured product. We are excited to be working with them to have a solution that works in our cell therapy business unit. This technology has the potential to impact the space by driving down cost of goods and simplifying manufacturing, product characterization and release of cell therapy products. I’m passionate about bringing cell therapy to everyone who needs it and I believe our partnership with InDevR will help us do that for our partners and our patients.”